We have recently reported the synthesis and antifungal activity of imidazolidinone derivatives with the general formula 1 (Chart 1). 1) These compounds exhibited strong growth inhibitory activity against not only yeasts such as Candida albicans and Cryptococcus neoformans but also against molds such as Aspergillus fumigatus, as well as potent protective effects against candidiasis and aspergillosis in mice. From these imidazolidinones, 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3- [4-(1H-1,2,3-triazol-1-yl) phenyl]-2-imidazolidinone (1a) and 1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3- [4-(1H-1-tetrazolyl) phenyl]-2-imidazolidinone (1b) were selected for further biological evaluation to determine a candidate for clinical trials.
As we have previously described, 1) compounds 1a and 1b were prepared from the optically active synthetic intermediates, 2, 4 and 5, which were derived from (R)-and (S)-lactic acid esters as shown in Chart 2. Compound 1a was obtained in an overall yield of 33% from the oxirane 2 by ring opening with 7a followed by catalytic reduction, and 1b was obtained via SN2 displacement with the anion derived from 7b in either four steps from the oxiranylethanol 4 or seven steps from the hydroxypropiophenone 5 in overall yields of 1.7% and 0.9%, respectively. Although these procedures were useful for the synthesis of a wide variety of optically active 1,2,3-trisubstituted-2-butanols, [1] [2] [3] the overall yields for the synthesis of 1a and 1b by these routes are low. We therefore needed to develop a higher-yielding synthetic procedure to supply sufficient quantities required for the detailed biological evaluation of 1a and 1b. In this paper we describe a new route for the efficient synthesis of the novel antifungal agents, 1a and 1b, starting from the oxirane 2.
The main cause of the low yield in our previous synthesis was considered to be the low reactivity of the anion of the imidazolones 7a and 7b to nucleophilic substitution. Therefore, we devised an alternative retrosynthetic pathway, in which the imidazolone-or imidazolidinone ring is formed by intramolecular cyclization after introduction of the appropriate functionality into the butanol framework (Chart 3). Thus the 2-substituted ethylamine moiety is first introduced into the 3-position of the oxirane 2 to give the aminoalcohol III whose secondary amino group is sufficiently basic to allow addition of an N-substituted carbamoyl group to give the urea II. Intramolecular cyclization utilizing the functional groups (R 1 and R 2 ) then allows synthesis of the desired skeleton I. The synthetic routes initially investigated are shown in Chart 4. The oxirane 2 was allowed to react with 2,2-diethoxyethylamine [H 2 NCH 2 CH(OEt) 2 ] in the presence of titanium tetraisopropoxide [Ti(O-isoPr) 4 ] 4) in propanol (PrOH) Optically Active Antifungal Azoles. XI. to give the ring-opened product 8, which is the key intermediate in this synthetic route, as an oil in 81% yield. For the synthesis of 1a, compound 8 was reacted with phenyl 4-(1H-1,2,3-triazol-1-yl)phenylcarbamate (10a) at 110°C in N,Ndimethylformamide (DMF) to give the urea 9a (94% isolated yield). Intramolecular cyclization was achieved by heating 9a in the presence of methanolic hydrochloric acid (HClMeOH) to form the imidazolone 3a in 84% yield. The synthesis could also be carried out without purification of the intermediate 9a, resulting in a slightly improved overall yield of 3a from 8 (83%). Catalytic hydrogenation of 3a over palladium on carbon (Pd-C) in acetic acid (AcOH) using the conditions described in our preceding report afforded 1a. This synthetic route, which allowed the preparation of 1a in 58% overall yield from the starting material 2, was then applied to the synthesis of the 1-tetrazolylphenylimidazolone derivative 1b. Thus compound 8 was reacted with phenyl 4-(1H-1-tetrazolyl)phenylcarbamate (10b) and then cyclized and hydrogenated as described above to give 1b in 40% overall yield from 2. The synthesis of 1b was also carried out by an alternative route using commercially available 4-nitrophenyl isocyanate (4-NO 2 PhNCO) instead of 10b. Room temperature reaction of 8 with 4-NO 2 PhNCO gave the nitrophenylurea 11 in 81% isolated yield, which was then cyclized to the imidazolone 12 (86%). When the synthesis was carried out without purification of 11, the overall yield of 12 from 8 was improved slightly to 80%. The nitro group and the double bond were simultaneously reduced by catalytic hydrogenation on Pd-C to afford the aminophenylimidazolidinone 13 in a moderate yield (52%). The amino group of 13 was converted into a tetrazole ring in 55% isolated yield by reaction with sodium azide (NaN 3 ) and ethyl orthoformate [CH(OEt) 3 ] in the presence of AcOH. Using this route, 1b was obtained in 19% overall yield from 2.
1) An Alternative Synthetic Route for 1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-imidazolidinone (TAK-456) and Its Analog
On the basis of results of detailed biological studies carried out on compounds 1a and 1b, compound 1b (TAK-456) was selected as the candidate for clinical trials. Therefore, a more practical pathway for the large scale synthesis of 1b was now required, since the previous synthetic routes involved a moderate yielding conversion of imidazolone to imdazolidinone, i.e., 3b→1b (64%) and 12→13 (52%), by catalytic hydrogenation. Thus we devised an alternative route to synthesize the imidazolidinone ring by direct cyclization of the hydroxyethyl precursor II (R 1 ϭH, R 2 ϭOH: Chart 3). The route for the alternative synthesis for 1b is shown in Chart 5. The oxirane ring-opening reaction of 2 with 2-aminoethanol [H 2 N(CH 2 ) 2 OH] was successfully carried out using similar reaction conditions to those used in the synthesis of 8, to give the hydroxyethylaminobutanol 14 as an oil in 89% yield. Condensation of 14 with the carbamate 10b (0.8 eq) in the presence of triethylamine (Et 3 N) in ethyl acetate (AcOEt) at reflux resulted in the precipitation of 15 from the reaction mixture (86% yield from 10b). Several reaction conditions were examined for the ring closure of 15 to give the imidazolidinone and initially it seemed that the Mitsunobu reaction 5) using diethyl azodicarboxylate (DEAD) and triphenylphosphine (Ph 3 P) would be able to affect direct ring closure. However, this reaction was found to proceed via 2 pathways, which in addition to giving the desired product 1b (67% yield), also produced the undesired morpholine derivative 25 6) (12% yield) as a byproduct. We next examined a 2-step cyclization via initial conversion of 15 to the chloride 16 followed by dehydrochlorination with base to give 1b. Treatment of 15 with thionyl chloride (SOCl 2 ) afforded the chloride 16 in 43% yield, but an improved isolated yield (70%) was obtained by using phosphorous oxychloride (POCl 3 ), and dehydrochlorination of 16 with Et 3 N gave the imidazolidinone 1b in 71% yield. Furthermore, this two-step cyclization reaction could be carried out as a one-pot process. Thus POCl 3 was added to a solution of 15 in AcOEt and N,N-dimethylacetamide (DMA), and the subsequent addition of Et 3 N gave the product 1b in 74% overall yield from 15.
As described above (Chart 4), 1b was also obtained by tetrazole ring formation at the amino group of 13, although the yield of the preceding hydrogenation step to synthesize 13 was moderate (52%). Therefore, in order to improve the yield of 13, we investigated its synthesis from 14 via the imidazolidinone cyclization route we have established. Ring closure of 17 using POCl 3 -Et 3 N to give 18 and subsequent catalytic hydrogenation to give 13 proceeded successfully in 81% yield and in 75% yield, respectively. However the initial step to synthesize 17 by introduction of the N-nitrophenylcarbamoyl moiety onto the secondary amino group of 14 proceeded in a poor yield (39%), probably due to the competing reaction of the primary hydroxyl group of 14 with the isocyanate.
Our synthesis of 1a and 1b above used the carbamate 10a and 10b as key synthetic intermediates. In our preceding report, 10a and 10b were prepared from the corresponding anilines 24a and 24b, which in turn were synthesized by reduction of the corresponding 4-azolylnitrobenzenes prepared by nucleophilic substitution of 4-fluoronitrobenzene with the appropriate azoles, i.e., 1,2,3-triazole and tetrazole. However, in both cases, an isomeric mixture of 1-substituted and 2-substituted azoles were obtained, which required separation at either the 4-azolylnitrobenzene or the 4-azolylaniline stage. 1) Clearly for the efficient large scale synthesis of 1a and 1b, we needed a method to selectively prepare the 1-substituted azole isomer. Thus a new route was devised for the synthesis of the carbamates 10a and 10b using p-nitroaniline (19) as the starting material (Chart 6), in which the 1-substituted 1,2,3-triazole derivative 20 was selectively synthesized by reaction with chloroacetaldehyde tosylhydrazone (ClCH 2 -CHϭNNHTs) according to the method described in a patent. 7) This enabled 20 to be obtained as crystals in 67% yield from the hydrazone, after which 10a could be obtained by reduction to 24a followed by treatment with phenyl chlorocarbonate (PhOCOCl) [overall yield from 20, 80%]. For the synthesis of the 1-substituted tetrazole derivative 10b, compound 19 was first converted quantitatively to 21 according to the method reported by Gaponik et al. 8) Subsequent reduction of 21 to 24b with hydrazine hydrate (N 2 H 4 · H 2 O) in the presence of ferric chloride (FeCl 3 ) followed by treatment with PhOCOCl afforded the carbamate 10b, in 82% overall yield from 19. In alternative approach, compound 19 was dibenzylated with benzyl bromide (PhCH 2 Br) in the presence of potassium carbonate (K 2 CO 3 ) to give 22 (82% yield), and the nitro group was reduced to amino group and then reacted with NaN 3 and CH(OEt) 3 to form the 1-substituted tetrazole 23 (63% yield). The dibenzyl group was removed by catalytic hydrogenolysis, and the resulting aniline 24b was converted to the carbamate 10b in 91% yield from 23.
In conclusion, we have established an efficient and practical route for the synthesis of the imidazolidinone-based antifungal triazoles, 1a and 1b. This route is suitable for application to large-scale production, since each reaction step proceeded in a good yield under mild conditions, and in addition all the synthetic intermediates were stable and easily purified. Pre-clinical studies on the selected candidate 1b (TAK-456) are currently in progress and detailed profiles of the biological activity of 1b will be reported in due course.
Experimental
Melting points were determined using a Yanagimoto melting point apparatus and are uncorrected. IR spectra were measured with JASCO IR-810 spectrometer.
1 H-NMR spectra were recorded on a Varian Gemini-200 spectrometer with tetramethylsilane as an internal standard. The following abbreviations are used: sϭsinglet, dϭdoublet, tϭtriplet, qϭquartet, mϭmultiplet and brϭbroad. The secondary ion mass spectra (SI-MS) were measured with a Hitachi M-80A mass spectrometer. The optical rotations were recorded with a Jasco DIP-181 or DIP-370 digital polarimeter.
Reactions were carried out at room temperature unless otherwise noted and followed by TLC on Silica gel 60 F 254 precoated TLC plates (E. Merck) or by HPLC using an octadecyl silica (ODS) column (A-303, 4.6 mm i.d.ϫ 250 nm, YMC Co., Ltd.). Standard work-up procedures were as follows. The reaction mixture was partitioned between the indicated solvent and water. Organic extracts were combined and washed in the indicated order using the following aqueous solutions: water, 5% aqueous sodium carbonate solution (aqueous NaHCO 3 ), saturated sodium chloride (NaCl) solution (brine), 1 N aqueous sodium hydroxide solution (1 N NaOH), 1 N hydrochloric acid (1 N HCl) and 5% aqueous phosphoric acid solution (5% H 3 PO 4 ). Extracts were dried over anhydrous magnesium sulfate (MgSO 4 ), filtered and evaporated in vacuo. Chromatographic separations were carried out on Silica gel 60 (0.063-0.200 mm, E. Merck) using the indicated eluents.
(2R,3R)-3-(2,2-Diethoxyethyl)amino-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2-butanol (8) A mixture of 2 (40 g), Ti(O-isoPr) 4 (68 g), H 2 NCH 2 CH(OEt) 2 (464 ml) and PrOH (400 ml) was stirred under reflux for 24 h under a nitrogen atmosphere. The solvent and H 2 NCH 2 CH(OEt) 2 were distilled off under reduced pressure. The residue was diluted with AcOEt (800 ml). 1 N NaOH-brine (1 : 1, v/v, 520 ml) was added and the resulting mixture was stirred for 1 h. A milky precipitate was filtered off and washed with AcOEt (250 ml). The filtrate and the washing were combined. The organic layer was extracted with 1 N HCl (150 mlϫ4). The aqueous extracts were combined and neutralized with 2 N NaOH (300 ml) at 0°C. The whole was worked up (AcOEt; 1 N NaOH, brine , 10a (137 mg) and DMF (2 ml) was stirred for 2 h at 110°C under an argon atmosphere. The reaction mixture was cooled and worked up (AcOEt; water, brine). The residue was purified by silica gel column chromatography (AcOEt-hexane, 3 : 1, v/v→ AcOEt) to give 9a (262 mg, 94%) as a white powder. Anal. Calcd for C 27 H 32 F 2 N 8 O 4 : C, 56.83; H, 5.65; N, 19.64. Found: C, 56.71; H, 5.76 : Ϫ107.1°(cϭ1.0, MeOH).
1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1,2,3-triazol-1-yl)phenyl]-2-(1H,3H)-imidazolone (3a)
1) 2 N HCl (2.4 ml) was added to a solution of 9a (228 mg) in MeOH (2.4 ml). The mixture was stirred for 4 h at 60°C and cooled. After having been neutralized with 1 N NaOH (4.8 ml), the whole was concentrated in vacuo and worked up (AcOEt; water, brine). The residue was crystallized from AcOEt-diisopropyl ether (isoPr 2 O) to give 3a (161 mg, 84%) as white powdery crystals.
2) A mixture of 8 (16 g), 10a (11.66 g) and DMF (160 ml) was stirred for 2 h at 110°C under an argon atmosphere. The mixture was cooled and worked up (AcOEt; water, brine). The residue was dissolved in MeOH (210 ml), and then 2 N HCl (210 ml) was added to the solution. The mixture was stirred for 6 h at 60°C and cooled. After having been concentrated in vacuo, the remaining aqueous solution was washed with isoPr 2 O (200 ml) and neutralized with 1 N NaOH (420 ml). The whole was extracted with AcOEt and the extract was washed with brine. The organic layer was dried over MgSO 4 and concentrated in vacuo. The residue was crystallized from AcOEtisoPr 2 O to give 3a (18 g), which was then recrystallized from AcOEt to give white powdery crystals (16.5 g, 83% from 8).
Compound 3a was hydrogenated to 1a in the same manner as that described in our preceding report.
1) Compounds 3a and 1a were identical to the authentic sample 1) upon direct comparison .  1-(2,2-Diethoxyethyl)-1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl) phenyl]-urea (9b) A mixture of 8 (30 g), 10b (21.9 g) and DMF (300 ml) was stirred for 5 h at 80°C. The reaction mixture was cooled and worked up (AcOEt; water). The residue was crystallized from AcOEt-isoPr 2 O to give 9b (35.7 g) as white powdery crystals. The mother liquor was concentrated in vacuo and the residue was purified by silica gel column chromatography (AcOEthexane, 3 : 1, v/v→AcOEt) to obtain an additional amount of 9b (4 g 1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-(1H,3H) -imidazolone (3b) 2 N HCl (342 ml) was added to a solution of 9b (39 g) in MeOH (342 ml). The mixture was stirred for 17 h at 50-55°C and cooled. After having been neutralized with 2 N NaOH (342 ml), the whole was concentrated in vacuo and worked up (AcOEt; water, brine). The residue was crystallized from AcOEt-isoPr 2 O to give 3b (28.6 g, 87%) as white powdery crystals. This product was identical to 3b prepared in our preceding report 1) upon direct comparison with the authentic sample. 
1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-(4-nitrophenyl)-2-(1H,3H)-imidazolone (12)
) 1 N HCl (2.8 ml) was added to a solution of 11 (0.15 g) in MeOH (3 ml). The mixture was stirred under reflux for 2 h and cooled. After having been neutralized by addition of NaHCO 3 (0.24 g) at 0°C, the whole was worked up (AcOEt; water, brine) to give 12 (0.11 g, 86%) as a pale yellow powder. 
. 2) A mixture of 8 (8.9 g), 4-NO 2 PhNCO (4.2 g) and dimethyl sulfoxide (DMSO, 30 ml) was stirred for 2 h, and the whole was worked up (AcOEt; water; brine). The residue was dissolved in MeOH (180 ml) and treated with 2 N HCl (115 ml) in a manner similar to that described above. The precipitate was filtered off, and the filtrate was neutralized by addition of NaHCO 3 (19.3 g). The whole was concentrated in vacuo and worked up (AcOEt; water, brine). The residue was purified by silica gel column chromatography (AcOEt-hexane, 2 : 1, v/v) to give 12 (8.6 g, 80% from 8) as a pale yellow powder.
(
2R,3R)-2-(2,4-Difluorophenyl)-3-(2-hydroxyethyl)amino-1-(1H-1,2,4-triazol-1-yl)-2-butanol (14)
A mixture of 2 (30 g), Ti(O-isoPr) 4 (51 g), H 2 N(CH 2 ) 2 OH (109.4 g) and PrOH (300 ml) was refluxed for 7.5 h under a nitrogen atmosphere. After having been cooled, the mixture was diluted with AcOEt (500 ml) and 2 N NaOH (98 ml) saturated with NaCl. The resulting mixture was stirred for 30 min, diluted with brine (195 ml) and stirred for a further 10 min. The supernatant was separated by decantation. AcOEt (400 ml) was added to the aqueous layer, and the mixture was stirred vigorously for 3 min. The supernatant was separated again by decantation. Addition of AcOEt (300 ml each) followed by separation of the supernatant was repeated two more times. The supernatants were combined, washed with brine (250 ml) and extracted with 1 N HCl (225 mlϫ2). The acidic aqueous extracts were combined and neutralized at 0°C with 2 N NaOH (230 ml) saturated with NaCl. The whole was extracted with AcOEt and the extract was washed with brine. The organic layer was dried over MgSO 4 1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-1-(2-hydroxyethyl)-3-[4-(1H-1-tetrazolyl) phenyl]urea (15) A mixture of 14 (34.2 g), 10b (23.7 g), Et 3 N (17.6 ml) and AcOEt (600 ml) was stirred under reflux for 1.5 h. After having been cooled, the mixture was stirred for 2 h at 0°C. The precipitate was collected by filtration, washed with AcOEt (50 ml) and dried at 40°C in vacuo to give 15 (37.9 g, 86% based on 10b) as white powdery crystals. mp 172-175°C. Anal. 
1-(2-Chloroethyl)-1-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-urea (16)

1-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-3-(4-nitrophenyl)-2-imidazolidinone (18)
A solution of POCl 3 (0.88 ml) in AcOEt (10 ml) was added dropwise to a solution of 17 (3 g) in DMA-AcOEt (1 : 1, v/v, 30 ml) over a period of 20 min at around 21°C. The mixture was stirred for 16 h, and then Et 3 N (8.8 ml) was added dropwise over a period of 20 min at Ϫ5°C. The whole was stirred for 2 h and worked up (AcOEt; water, 5% H 3 PO 4 , aqueous NaHCO 3 , brine). The residue was purified by silica gel column chromatography (AcOEt-hexane, 6 : 1, v/v) to give 18 (2.3 g, 81%) as a pale yellow powder. Anal. Calcd for C 21 H 20 F 2 N 6 O 4 : C, 55.02; H, 4.40; N, 18.33. Found: C, 54.70; H, 4.44; N, 17.95 . Aminophenyl)-3-[(1R,2R)-2-(2,4-Difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-2-imidazolidinone (13) 1) A solution of 12 (1 g) in AcOH (15 ml) was hydrogenated over 10% Pd-C (1 g) for 7 h at 40-45°C. The catalyst was filtered off and washed with AcOH (30 ml). The filtrate and the washing were combined and concentrated in vacuo. The residue was purified by silica gel column chromatography (AcOEt-hexane, 9 : 1, v/v→AcOEt) and crystallized from AcOEt to give 13 (0.48 g, 52%) as white powdery crystals. mp 192-193°C : Ϫ62.5°(cϭ1.0, MeOH). 2) A mixture of 18 (1 g), AcOEt (18 ml) and water (2 ml) was hydrogenated over 10% Pd-C (0.5 g) for 3 h. The catalyst was filtered off and washed with AcOEt (50 ml). The filtrate and the washing were combined and concentrated in vacuo. The residue was crystallized from AcOEt to give 13 (0.35 g) as white powdery crystals. The mother liquor was concentrated in vacuo, and the residue was purified by silica gel column chromatography 3 : 1, v/v) (27 g) in AcOH (500 ml) was hydrogenated over 10% Pd-C (27 g) for 48 h at 40°C under a pressure of 50 kg/cm 2 . The catalyst was filtered off and washed with AcOH (100 ml). The filtrate and the washing were combined and concentrated in vacuo. The concentrate was worked up (AcOEt; brine), and the residue was crystallized from EtOH (1000 ml) to give 1b (17.45 g, 64%) as colorless powdery crystals.
1-(4-
2) NaN 3 (0.18 g) and AcOH (2 ml) were added successively to a mixture of 13 (1 g) and CH(OEt) 3 (1.16 ml). The mixture was stirred for 20 min and for further 1.5 h at 80-85°C under an argon atmosphere. After having been cooled, the mixture was diluted with water (2 ml) and 6 N HCl (0.85 ml). A 25% aqueous solution of sodium nitrite (25% NaNO 2 , 0.3 ml) was added, and the resulting mixture was cooled in an ice bath. The precipitate was collected by filtration, washed with water and recrystallized from EtOH to give 1b (0.62 g, 55%) as colorless crystals.
3) A solution of 15 (0.2 g) in tetrahydrofuran (THF, 6 ml) was added dropwise over a period of 5 min to a mixture of Ph 3 P (0.145 g), a 40% solution of DEAD in toluene (0.24 g) and THF (6 ml) at Ϫ20°C. The resulting mixture was stirred for 2 h. The solvent was distilled off in vacuo, and the residue was chromatographed on silica gel 4 : 3 : 3, v/v→ AcOEt) . From the first eluate, 1b was obtained as colorless powdery crystals (0.118 g, 67%). From the second eluate, the morpholine derivative 25 (0.021 g, 12%) was obtained as a white powder. Compound 25:
1 H-NMR (CDCl 3 ) d: 1.19 (3H, d, Jϭ6.8 Hz), m), m), 4.68 (1H, d, Jϭ14.5 Hz), 5.04 (1H, d, Jϭ14.5 Hz), m), 7.32 (2H, d, Jϭ8.8 Hz), 7.57 (2H, d, Jϭ8.8 Hz), m), 8.03 (1H, br), 8.93 (1H, s) . SI-MS (m/z): 482 (MH ϩ ). 4) A solution of Et 3 N (0.96 ml) in AcOEt (2 ml) was added dropwise to a solution of 16 (1.2 g) in DMA-AcOEt (3 : 5, v/v, 16 ml) over a period of 15 min at an internal temperature of 0-2°C. After having been stirred for 3 h, the mixture was diluted with ice-water (20 ml) and worked up (AcOEt; water, 5% H 3 PO 4 , aqueous NaHCO 3 , brine). The residue was crystallized from AcOEt to give a white powder, which was then recrystallized from EtOH to give 1b (0.765 g, 71%) as colorless crystals.
5) A solution of POCl 3 (1.41 ml) in AcOEt (15 ml) was added dropwise to a solution of 15 (5 g) in DMA-AcOEt (1 : 1,v/v, 50 ml) over a period of 1.7 h at 22-25°C. The mixture was stirred for 16 h, and then Et 3 N (12.8 ml) was added dropwise over a period of 20 min at around Ϫ4°C. After having been stirred for 5 h, the whole was diluted with ice-water (20 ml) and worked up (AcOEt; water, 5% H 3 PO 4 , aqueous NaHCO 3 , brine). The AcOEt layer was treated with activated carbon and concentrated in vacuo. The residue was crystallized from AcOEt to give a white powder, which was then recrystallized from EtOH to give 1b (3.4 g, 74%) as colorless crystals.
The product 1b prepared by the methods described above was identical to the authentic sample 1) upon direct comparison. Phenyl 4-(1H-1,2,3-Triazol-1-yl)phenylcarbamate (10a) A mixture of 19 (14.75 g), Cl 2 CHCHϭNNHTs (10 g) and MeOH (400 ml) was stirred for 1 h at around Ϫ3°C. After having been stirred overnight, the mixture was concentrated in vacuo to a volume of about 170 ml. The concentrate was allowed to stand in an ice-bath for 30 min. The precipitate was collected by filtration to give 20 (4.04 g) as pale yellow crystals. The mother liquor was concentrated in vacuo, and the residue was dissolved in AcOEt-THF (1 : 1, v/v, 400 ml). The solution was washed with 1 N HCl, 1 N NaOH, water and brine, successively. The organic layer was dried over MgSO 4 and evaporated in vacuo. The residue was crystallized from Et 2 O to give an additional amount of 20 (0.47 g). Yield 4.51 g (67% based on the hydrazone).
A mixture of 20 (33.33 g), EtOH (200 ml) and THF (200 ml) was hydrogenated over 10% Pd-C (50% wet, 4 g) at 50°C for 6 h. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. The residue was crystallized from isoPr 2 O to give 24a (27.45 g, 94%) as pale yellow powdery crystals.
PhOCOCl (28.5 g) was added dropwise over a period of 15 min to an icecooled solution of 24a (26.45 g) in acetone (550 ml) containing pyridine (14.4 g). After having been stirred for 1 h, the mixture was concentrated in vacuo. The concentrate was worked up (AcOEt-THF, 2 : 1, v/v; water, brine). The residue was crystallized from isoPr 2 O to give 10a (39.68 g, 85%). Compounds 20, 24a and 10a were identical to the authentic samples 1) upon direct comparison.
N,N-Dibenzyl-p-nitroaniline (22) A mixture of 19 (10 g), PhCH 2 Br (49.5 g), K 2 CO 3 (22 g) and DMF (50 ml) was stirred for 32 h at 160°C. After having been cooled, the mixture was worked up (AcOEt; water, brine). The residue was crystallized from isoPr 2 O-hexane to give 22 (19 g, 82%) as pale yellow crystals. .2 g) and MeOH (120 ml) was stirred under reflux for 30 min. N 2 H 4 · H 2 O (27.4 ml) was added dropwise under reflux over a period of 1 h. The resulting mixture was stirred under reflux for 24 h and cooled. Activated carbon (2.2 g) and FeCl 3 (0.55 g) were added, and the mixture was refluxed for 10 min. N 2 H 4 · H 2 O (27.4 ml) was added dropwise under reflux over a period of 1 h. The resulting mixture was stirred under reflux for further 24 h. After having been cooled, the whole was filtered to remove the activated carbon, and the filtrate was concentrated in vacuo. The concentrate was worked up (AcOEt; water, brine) and crystallized from hexane-isoPr 2 O to give N,N-dibenzyl-p-phenylenediamine (15 g, 92%) as purple crystals. AcOH (40 ml) was added dropwise over a period of 10 min to a mixture of N,N-dibenzyl-p-phenylenediamine (15 g) prepared above, CH(OEt) 3 (25.5 ml) and NaN 3 (4 g). The mixture was stirred for 5 min and for further 4 h at 90°C under a nitrogen atmosphere. After having been cooled, the mixture was diluted with water (50 ml) and 6 N HCl (18 ml). A solution of NaNO 2 (2 g) in water (8.4 ml) was added, and the whole was cooled in an ice-bath. The precipitate was collected by filtration and recrystallized from EtOH-MeOH-THF to give 23 (12.4 g, 68%) as brown scaly crystals. Phenyl 4-(1H-1-Tetrazolyl)phenylcarbamate (10b) 1) Methyl orthoformate [CH(OMe) 3 , 2.74 ml] was added to a mixture of 19 (3 g) and AcOH (18 ml). The mixture was stirred for 30 min, and then NaN 3 (2.35 g) was added. The resulting mixture was stirred for 2 h at 83°C. After having been cooled, the mixture was diluted with water (18 ml) and 6 N HCl (5 ml). A solution of NaNO 2 (1.2 g) in water (3.6 ml) was added dropwise over a period of 5 min. The whole was stirred for 1 h in an ice-bath. The precipitate was collected by filtration and washed with water to obtain 21 as a wet solid. This solid was dissolved in THF (60 ml) at 60°C. FeCl 3 (39.1 mg) and activated carbon (413 mg) were added to the solution, and then N 2 H 3 · H 2 O (3.79 ml) was added dropwise over a period of 30 min under reflux. The resulting mixture was stirred under reflux for 2.5 h and cooled. The activated carbon was removed by filtration and washed with AcOEt (30 ml). The filtrate and the washing were combined and washed with brine. The organic layer containing 24b was dried over MgSO 4 . The solution was cooled in an ice-bath, and pyridine (2.06 g) was added. PhOCOCl (4.08 g) was added dropwise to the solution over a period of 5 min. After having been stirred for 1h, the whole was worked up (AcOEt; brine, water, brine). The residue was crystallized from isoPr 2 O to give 10b (5.05 g, 83% over all yield from 19).
2) A mixture of 23 (2 g), MeOH-THF (2 : 1, v/v, 30 ml) and 6 N HCl (1 ml) was hydrogenated over 10% Pd-C (0.5 g) for 25 min. The catalyst was removed by filtration, and the filtrate was concentrated in vacuo. The residue was dissolved in a mixture of AcOEt-THF (2 : 1, v/v, 45 ml) and water (5 ml) , and a solution of NaHCO 3 (1.3 g) in water (20 ml) was added dropwise under ice-cooling over a period of 5 min. PhOCOCl (0.89 g) was added dropwise to the solution over a period of 5 min. Water (10 ml) was added, and the resulting mixture was stirred for 30 min. The organic layer was worked up (brine). The residue was crystallized from isoPr 2 O to give 10b (1.5 g, 91%) .
The product 10b obtained above was identical to the authentic sample 1) upon direct comparison.
